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INTRODUCTION
Metabolic syndrome is a collection of health risks that increase
the chance of developing heart disease, stroke and diabetes.1
The prevalence rate in many western countries is 22-23%.
According to a national health survey, more than one in 5
Americans has metabolic syndrome. Recently released  third
report of the National Cholesterol Education Program Expert
Panel on detection, evaluation, and treatment of high blood
cholesterol in adults (ATP-III) draws attention to the
importance of the metabolic syndrome and provides a working
definition of this syndrome for the first time,2 which may be
defined as presence of (i) central obesity among men with
waist Ž 102 centimeter(cm) (40 inches) and among women
with waist  Ž  88 cm (34 inches), (ii) blood pressure Ž 130 /85
mmHg, (iii) triglycerides Ž 150 mg/dl, (iv) HDL: men < 40 mg/dl
and women < 50 mg/dl and (v) fasting glucose Ž 110 mg/dl.
The diagnosis is made when three or more of these risk
factors are present.  Acquired factors such as excess body fat
and physical inactivity may also lead to metabolic syndrome.3,4
For adults in Asia-Pacific region, BMI more than 23 is
overweight while BMI greater than 25 is termed obesity
according to WHO International Association for the study of
obesity and international obesity task force that increases the
risk of metabolic syndrome. Metabolic syndrome is on the rise
worldwide. Relevant information regarding distribution of
metabolic syndrome is limited in local literature. The aim of this
study was to determine the frequency of metabolic syndrome
among patients attending an out-patient clinic of a teaching
hospital and to compare the clinical features regarding
metabolic syndrome among males and females.
PATIENTS AND METHODS
It was a cross-sectional study, conducted at the out-patient
clinics of the Aga Khan University Hospital (AKUH), Karachi,
from December 2004 to April 2005.
Inclusion criteria were males or females of at least 25 years of
age and appearing for a regular check-up at the Family
Medicine and Executive Clinic set-up of AKUH, were
eligible to participate in the study.
All those who were eligible but did not give their informed
consent to participate in the study were excluded.
Data were collected for height (cm), weight (kg), waist
circumference (cm) – at narrowest point between umbilicus
and ribcage, systolic and diastolic blood pressure (mmHg),
fasting serum levels for sugar, triglycerides (TG), total
cholesterol Low Density Lipoprotein(LDL) and High Density
Lipoprotein (HDL).
Metabolic syndrome was characterized to be present when
any three of the following were found to be positive as defined
by ATPIII guidelines: (i) waist circumference for males Ž 102
cm; for females Ž 88 cm,  (ii) blood pressure Ž 130 /85 mmHg,
iii) triglycerides Ž 150 mg/dl,  (iv) HDL for males < 40 mg/dl for
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females < 50 mg/dl or (v) fasting blood glucose Ž 110 mg/dl.
Body Mass Index (BMI) was calculated by the standard
formula; weight in kg/height in meter.2
Frequencies and percentages were computed to report the
primary objective of the study. We compared between gender
differences for age, weight, height, waist circumference, blood
pressure, fasting serum levels for sugar, triglycerides, total
cholesterol, LDL and HDL by using the t-test. Differences
between males and females regarding number of metabolic
syndrome risk factors were assessed using the chi-square
test. Fischer’s exact test was used where the cell count was
less than 5. Data were analyzed using Statistical Package for
Social Sciences (SPSS).
RESULTS 
A total of 250 subjects were enrolled in this study. Of these,
157 (62.8%) were male. The average age of the study
participants was 48.94 years ± Standard Deviation (SD) 10.62.
Their mean age, compared to females, was not significantly
different (Table I). Information on smoking was available for
100 participants only. Of the 57 males, who provided
information on smoking, 13 (22.8%) reported current smoking.
Males differed from females when compared for waist
circumference, TG, HDL and BMI. While they were similar
regarding fasting blood sugar (p-value 0.58) and other factors
(Table I). 
Using standard cut off levels of individual risk factors for
metabolic syndrome, the distribution was as follows; of the  47
(30%) males had a waist circumference Ž 102 cm while 54
(58%) among females had a waist circumference Ž 88 cm. A
quarter of males, 38 (24.2%) and a similar proportion of
females, 24 (25.8%), had blood pressure Ž 130/85 mmHg. The
difference among males and females regarding triglyceride
levels was only marginal, where 87 (55.4%) and 63 (67.7%)
respectively had triglyceride levels Ž 150 mg/dl (p-value 0.05).
A greater proportion of both males and females had HDL
levels within recommended levels i.e. 92 (58.6%) males had
HDL concentration • 40 mg/dl; while 57 (61.3%) females had
HDL concentration • 50 mg/dl. No significant difference was
found between males and females, with respect to fasting
blood glucose levels, where 105 (67%) and 55 (59%)
respectively demonstrated fasting blood glucose levels Ž 110
mg/dl (p-value 0.22). 
Overall metabolic syndrome, as defined earlier, was found in
87 (35%) study participants i.e. those who had three or more
than three risk factors present (Table II). Among the males,
31.8% had metabolic syndrome while the proportion of
females with metabolic syndrome was 39.8%. The females
were found to be only marginally different (p-value 0.05)
compared to males regarding presence of at least four risk
factors (Table II). Age adjusted distribution of 87 participants
with metabolic syndrome showed that 38 (43.7%) were in the
age group 51-60, while 24 (27.6%) were in the age group 41-
50 (Table III).
DISCUSSION 
The diagnosis of metabolic syndrome in patients might hold
promise for enhanced prevention of diabetes and
cardiovascular disease. According to ATP-III guidelines, the
diagnosis of metabolic syndrome is made when at least three
factors among obesity, raised blood pressure, raised fasting
blood glucose, raised triglycerides or decreased HDL are
present in an individual.  Based on these guidelines, more
than 1/3 rd of the study participants  had metabolic syndrome. 
In the United States,  24% men and 23% women had
metabolic syndrome whereas a cohort study showed
increasing frequency in metabolic syndrome with an increase
in age. 5-7 Increase in blood pressure, waist circumference
and hypertriglyceridemia accounted for much of the increase
in prevalence, particularly in women. In this study  also
hypertriglyceridemia was more common in women as
compared to men while 58% women were centrally obese that
is waist circumference >88cm. Overall high blood pressure
was seen in 24.8% of our study population, where both males
and females were similar regarding systolic and diastolic blood
pressure.  Physical inactivity and excess weight have been
shown to be the main underlying contributors to the
development of metabolic syndrome.8
A study comparing two possible definitions of metabolic
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Table I:    Comparison of male and female study participants regarding 
metabolic syndrome risk factors.
Factors Male  Female P-value
(n = 157) (n = 93)
Mean Standard Mean Standard
deviation deviation
Age (in years) 48.57 11.19 49.57 9.62 0.47
Waist (in cm) 96.61 11.64 89.35 9.02 0.00
BMI* 27.09 4.91 28.58 5.07 0.02
TG† 164.42 97.54 134.34 64.27 0.01
HDL‡ 40.18 7.60 48.09 10.51 0.00
Cholesterol 190.60 34.75 198.27 44.41 0.13
LDL§ 119.59 28.62 121.06 35.30 0.72
Systolic BP|| (mmHg) 128.63 21.71 143.05 139.93 0.21
Diastolic BP (mmHg) 82.23 10.13 80.66 11.09 0.25
* Body mass index, † triglycerides, ‡ high density lipoproteins, § low density lipoproteins and ||
blood pressure.
Table II:   Frequency of risk factors for metabolic syndrome among 
study participants (n=250).
Factors Male  Female p-value
(n = 157) (n = 93)
n % n %
0 23 (14.6) 14 (15.1) 0.93
1 41 (26.1) 18 (19.4) 0.22
2 43 (27.4) 24 (25.8) 0.79
3 32 (20.4) 16 (17.2) 0.54
4 14 (8.9) 16 (17.2) 0.05
5 4 (2.5) 5 (5.4) 0.30*
*Fischer’s exact test used, due to low cell count
Table III:    Metabolic syndrome in different age groups. 
Metabolic syndrome  (n = 87)
Age groups n                      %





71+ 2 2.3 
syndrome showed two different prevalence rate  that is 23.9%,
using ATP-III guidelines and 25.1%, using WHO definition.9 A
previous study in Pakistan reported a 2.7% prevalence of
metabolic syndrome, however, this study did not follow ATP -
III guidelines to define metabolic syndrome.10 Some of the
studies conducted in the west have shown similar prevalence
of 35% as reported in this study. Jaber has reported 23%
prevalence of metabolic syndrome among Arab Americans by
using ATP-III guidelines,  prevalence increased with age
and BMI in both genders. However, the most important
components were low HDL and glucose intolerance.11 This
study has also shown  that  a greater proportion of study
participants had  glucose intolerance (64%) as well as low HDL
(59.6%). Metabolic syndrome has previously been found in
21% of study participants in Oman with 19.5% males and 23%
females. In the same study, low HDL was demonstrated as
prominent component while abdominal obesity was present
among 24.6% participants without any gender difference.12
However, we have shown a significant difference regarding
mean HDL concentration among males and females.
Obesity was common in this study where 78.8% of total
participants had BMI more than 25. Males had a significantly
higher mean waist circumference (mean ± SD: 96.6 cm
±11.64) compared to females (89.35 cm ± 9.02) which
highlights the importance of central obesity as a risk factor for
metabolic syndrome.13,14 This study also demonstrated a
significant difference in the average BMI of males (27.09 ±
4.91) and females (28.58 ±5.07). 15,16 
Male Pakistani migrants have previously been shown to have
significantly more abdominal adiposity relative to total
adiposity in a study conducted to measure generalized obesity
and regional distribution of adiposity among adult white and
migrant Muslim males from Pakistan in Peterborough,
Canada.17 However, female participants were more obese
than male study participants with a significantly higher mean
BMI.
In a previous study which involved women of age Ž 25 years
from an urban setting in Karachi, Pakistan, 42% and 8% were
found to be overweight and obese respectively. This shows a
preponderance of obesity among females in similar settings.18
Rogers described impact of metabolic syndrome on long-term
outcomes in simultaneous kidney – pancreas transplantation.
Out of 241 patients, 59% of pre-transplantation patients had
metabolic syndrome. Presence of metabolic syndrome at one
year was associated with long-term renal dysfunction after
kidney pancreas transplantation.19
The goal of identifying metabolic risk factors is to prevent
morbidity and mortality due to type 2 diabetes and
cardiovascular disease. In individuals who have even normal
LDL levels,  there is a high risk of getting premature coronary
artery disease.20 The role of family physicians is important as
they are the first line of health care providers to encounter
patients and to provide preventive measures besides taking
steps to reverse metabolic syndrome in those who have a
combination of risk factors 21 (Table II).
Age adjusted distribution of metabolic syndrome in this study
showed that out of 87 patients who had metabolic syndrome,
43.7% were in the age range of 51-60 years and 27.6% were
in the age range 41-50 years.5-7,11,12 (Table III). Since physical
inactivity and excessive weight gain are the main underlying
contributors to the development of metabolic syndrome, as
demonstrated in this study also, getting more exercise and
loosing weight can help reduce or prevent the complications
associated with this condition. Most of the risk factors are
preventable and, identifying these at early stage at screening
clinics might be of significant help, as done elsewhere.22
The worldwide epidemic of type 2 diabetes is fuelled in large
part by a parallel epidemic of obesity and physical inactivity,
clearly pointing to prevention of obesity as the most direct
route to prevention of metabolic syndrome and its squalor.23
Hypertension, diabetes, obesity and ischemic heart disease
have become a problem of public health magnitude with
substantial economic burden not only in developed but also in
the developing countries.24,25 It is a family practitioner’s
responsibility to detect these non-communicable diseases in
patients’ first encounter with the physician and dealing with
each component either through a treatment strategy or
prevention of disease to prevent atherosclerotic
cardiovascular diseases and diabetes which are the principal
causes of death, disability and excess health care cost.26 -28
It is well established that metabolic syndrome is difficult to
manage and this study reports a similar burden as reported in
most of the western countries. One of the main contributory
factors is central obesity, which needs to be addressed more
aggressively among females who had a significantly higher
BMI compared to males, although males had a significantly
higher waist circumference. Individual risk factors need to
be corrected, however, prevention of these factors in the
community requires more awareness. Dietary and physical
activity practices that are learned at young age may be carried
into adulthood, establishing healthy lifestyles at an early age.
Testing effective strategies for prevention should have a
high priority in subsequent research involving metabolic
syndrome. Preventive measures require substantial political
will and financial investment; they should yield a rich dividend
to society in the long-term.  
CONCLUSION 
Frequency of metabolic syndrome in this study was
significantly high with predominant involvement of males and
prevalence is similar to that observed in developed countries.
Majority of patients had obesity and high fasting blood sugar
levels. Males demonstrated higher levels of triglycerides and
low levels of High-density Lipoprotein (HDL) compared to
females while blood pressure reading was observed to be the
same in both males and females.
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